DEXCOM INC — Director's Dealing 2018

Jul 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-07-16

Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-16	Common Stock	S	5600	$99.2322	Disposed	55282	Indirect
2018-07-16	Common Stock	S	3900	$99.8708	Disposed	51382	Indirect
2018-07-16	Common Stock	S	500	$100.73	Disposed	50882	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	441674	Direct
Common Stock	11461	Indirect

Footnotes

F1: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $98.64 and $99.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.

F4: This transaction was executed in multiple trades at prices ranging from $99.64 to $100.08. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.